Skip to main content

Advertisement

Log in

Clinical Oncology/Epidemiology

Reassessment of the relationship between M-protein decrement and survival in multiple myeloma

  • Clinical Oncology/Epidemiology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

The relationship between percentage M-protein decrement and survival is assessed in 134 multiple myeloma patients. The correlation did not achieve statistical significance (P = 0.069). Multivariate analysis using the Cox proportional hazards model, including a number of previously recognised prognostic factors, showed only percentage M-protein decrement, creatinine and haemoglobin to be significantly correlated with survival. However, the R'-statistic for each of these variables was low, indicating that their prognostic power is weak. We conclude that neither the percentage M-protein decrement nor the response derived from it can be used as an accurate means of assessing the efficacy of treatment in myeloma. Mature survival data alone should be used for this purpose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palmer, M., Belch, A., Hanson, J. et al. Reassessment of the relationship between M-protein decrement and survival in multiple myeloma. Br J Cancer 59, 110–112 (1989). https://doi.org/10.1038/bjc.1989.22

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1989.22

  • Springer Nature Limited

Navigation